{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:48:00Z","timestamp":1783050480232,"version":"3.54.6"},"reference-count":94,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.tcm.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T17:36:38Z","timestamp":1597599398000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["COVID-19 infection and cardiac arrhythmias"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0336-4745","authenticated-orcid":false,"given":"Antonis S.","family":"Manolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis A.","family":"Manolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora A.","family":"Manolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdoxia J.","family":"Apostolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Papatheou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Melita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2020.08.002_bib0001","first-page":"23","article-title":"Cardiovascular complications of the coronavirus (COVID-19) infection","volume":"15","author":"Manolis","year":"2020","journal-title":"Rhythmos"},{"key":"10.1016\/j.tcm.2020.08.002_bib0002","article-title":"Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies","author":"Parohan","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"5","key":"10.1016\/j.tcm.2020.08.002_bib0003","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","volume":"76","author":"Lala","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-020-02939-x","article-title":"Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study","volume":"24","author":"Yu","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.tcm.2020.08.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.06.016","article-title":"COVID-19 and cardiac arrhythmias","author":"Bhatla","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0006","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.tcm.2020.08.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/pace.13987","article-title":"Low prevalence of arrhythmias in clinically stable COVID-19 patients","author":"Sala","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjc.2020.05.004","article-title":"Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery","author":"Lazaridis","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0009","doi-asserted-by":"crossref","first-page":"E1867","DOI":"10.3390\/jcm9061867","article-title":"A pharmacovigilance study of hydroxychloroquine cardiac safety profile: potential implication in COVID-19 mitigation","volume":"9","author":"Singh","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0010","first-page":"215","article-title":"Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol","volume":"9","author":"Naksuk","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.tcm.2020.08.002_bib0011","first-page":"1","article-title":"A double-edged sword-cardiovascular concerns of potential anti-COVID-19 drugs","author":"Yu","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"10.1016\/j.tcm.2020.08.002_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0013","first-page":"1","article-title":"COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies","author":"Gopinathannair","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0014","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jinf.2020.05.068","article-title":"Cardiovascular complications in COVID-19: a systematic review and meta-analysis","volume":"81","author":"Kunutsor","year":"2020","journal-title":"J Infect"},{"issue":"28","key":"10.1016\/j.tcm.2020.08.002_bib0015","doi-asserted-by":"crossref","first-page":"E791","DOI":"10.1503\/cmaj.200879","article-title":"Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury","volume":"192","author":"Si","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.tcm.2020.08.002_bib0016","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s13054-020-03183-z","article-title":"Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.tcm.2020.08.002_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/clc.23384","article-title":"Cardiovascular manifestations in severe and critical patients with COVID-19","volume":"43","author":"Chen","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0018","first-page":"e8599","article-title":"Bradycardia in patients with COVID-19: a calm before the storm?","volume":"12","author":"Amaratunga","year":"2020","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.tcm.2020.08.002_bib0019","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cardfail.2020.06.005","article-title":"Electrocardiographic findings in COVID-19: insights on mortality and underlying myocardial processes","volume":"26","author":"McCullough","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.tcm.2020.08.002_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.06.009","article-title":"Behavior of the PR interval with increasing heart rate in patients with COVID-19","author":"Pavri","year":"2020","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.tcm.2020.08.002_bib0021","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/FJC.0000000000000854","article-title":"Atrial fibrillation in COVID-19: from epidemiological association to pharmacological implications","volume":"76","author":"Russo","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0022","first-page":"495","article-title":"Rhythm or rate control management of atrial fibrillation: an overrated dilemma","volume":"56","author":"Manolis","year":"2015","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa494","article-title":"New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people","author":"Holt","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2020.08.002_bib0024","article-title":"Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions","author":"Varshneya","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.tcm.2020.08.002_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Acute myocardial injury in patients hospitalized with COVID-19 infection: A review","author":"Bavishi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2020.08.002_bib0026","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.jacc.2020.04.016","article-title":"Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment","volume":"75","author":"Roden","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0027","doi-asserted-by":"crossref","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"Bmj"},{"key":"10.1016\/j.tcm.2020.08.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa508","article-title":"COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests","author":"Baldi","year":"2020","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.tcm.2020.08.002_bib0029","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2468-2667(20)30117-1","article-title":"Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study","volume":"5","author":"Marijon","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.tcm.2020.08.002_bib0030","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1302726","article-title":"Cardiovascular risks with azithromycin and other antibacterial drugs","volume":"368","author":"Mosholder","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105938","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"55","author":"Devaux","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tcm.2020.08.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.05.030","article-title":"Fatal arrhythmias: another reason why doctors remain cautious about chloroquine\/hydroxychloroquine for treating COVID-19","author":"Uzelac","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.tcm.2020.08.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.05.008","article-title":"QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review","author":"Jankelson","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1540-8159.2005.50146.x","article-title":"Polymorphic ventricular tachycardia with a normal QT interval following azithromycin","volume":"28","author":"Kim","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0036","first-page":"10","article-title":"Azithromycin causes a novel proarrhythmic syndrome","author":"Yang","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0037","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0038","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/135965350701200711","article-title":"Pharmacokinetics and pharmacodynamics of combined use of lopinavir\/ritonavir and rosuvastatin in HIV-infected patients","volume":"12","author":"van der Lee","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.tcm.2020.08.002_bib0039","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11596550-000000000-00000","article-title":"Clinical pharmacokinetics of fingolimod","volume":"51","author":"David","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.tcm.2020.08.002_bib0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/fcp.12284","article-title":"Fingolimod (Gilenya(\u00ae)) in multiple sclerosis: bradycardia, atrioventricular blocks, and mild effect on the QTc interval. Something to do with the L-type calcium channel?","volume":"31","author":"Pilote","year":"2017","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2042098613481023","article-title":"Fingolimod and cardiac risk: latest findings and clinical implications","volume":"4","author":"Vargas","year":"2013","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.tcm.2020.08.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017144","article-title":"Experience with hydroxychloroquine and azithromycin in the coronavirus disease 2019 pandemic: implications for QT interval monitoring","volume":"9","author":"Ramireddy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2020.08.002_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008662","article-title":"Effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2020.05.036","article-title":"Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin","author":"Cipriani","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0045","article-title":"An evaluation of co-use of chloroquine or hydroxychloroquine plus azithromycin on cardiac outcomes: A pharmacoepidemiological study to inform use during the COVID19 pandemic","author":"Vouri","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0046","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1968","article-title":"QT interval prolongation under hydroxychloroquine\/ azithromycin association for inpatients with SARS-CoV-2 lower respiratory tract infection","author":"Bun","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tcm.2020.08.002_bib0047","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1016\/j.jacc.2020.05.008","article-title":"Clinical trials and qt-prolonging prophylactic therapy in healthy subjects: first, do no harm","volume":"75","author":"Gollob","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0048","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","article-title":"Predicting the unpredictable: drug-induced qt prolongation and torsades de pointes","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.04.045","article-title":"Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans","author":"Giudicessi","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0050","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1161\/CIRCULATIONAHA.119.039598","article-title":"The QT interval","volume":"139","author":"Giudicessi","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2020.08.002_bib0051","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.amjcard.2003.12.055","article-title":"Assessment of prolonged QT and JT intervals in ventricular conduction defects","volume":"93","author":"Rautaharju","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0052","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.hrthm.2014.08.026","article-title":"New formula for evaluation of the QT interval in patients with left bundle branch block","volume":"11","author":"Bogossian","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0053","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2020.08.002_bib0054","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/jce.12976","article-title":"Comparison of QT interval readings in normal sinus rhythm between a smartphone heart monitor and a 12-lead ECG for healthy volunteers and inpatients receiving sotalol or dofetilide","volume":"27","author":"Garabelli","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0055","unstructured":"New FDA Guidance Allows Use of KardiaMobile 6L to Measure QTc in COVID-19 Patients. 2020. https:\/\/www.alivecor.com\/press\/press_release\/new-fda-guidance-allows-use-of-kardiamobile-6l-to-measure-qtc-in-covid-19-patients\/(Accessed June 12, 2020)."},{"issue":"4","key":"10.1016\/j.tcm.2020.08.002_bib0056","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCULATIONAHA.120.048253","article-title":"Validating QT-Interval measurement using the apple watch ECG to enable remote monitoring during the COVID-19 pandemic","volume":"142","author":"Strik","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2020.08.002_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.4960200318","article-title":"A practical approach to torsade de pointes","volume":"20","author":"Roden","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0058","first-page":"20","article-title":"Transvenous temporary cardiac pacing","volume":"9","author":"Poulidakis","year":"2014","journal-title":"Rhythmos"},{"key":"10.1016\/j.tcm.2020.08.002_bib0059","article-title":"Guidance on acute management of atrial fibrillation in COVID-19","author":"Rattanawong","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.tcm.2020.08.002_bib0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jacc.2013.04.009","article-title":"Inaccessibility to quinidine therapy is about to get worse","volume":"62","author":"Viskin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0061","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.111.019927","article-title":"Antiarrhythmic drug therapy for atrial fibrillation","volume":"125","author":"Zimetbaum","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2020.08.002_bib0062","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)38103-0","article-title":"In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes","volume":"289","author":"Nielsen","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.tcm.2020.08.002_bib0063","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00008571-199710000-00007","article-title":"Role of CYP2D6 in the N-hydroxylation of procainamide","volume":"7","author":"Lessard","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.tcm.2020.08.002_bib0064","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1002\/phar.1403","article-title":"An unusual case of flecainide-induced QT prolongation leading to cardiac arrest","volume":"34","author":"Oguayo","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.tcm.2020.08.002_bib0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0066","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2020.08.002_bib0067","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2020.08.002_bib0068","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF01488578","article-title":"Side effects and contraindications of beta-receptor blocking agents","volume":"55","author":"Lydtin","year":"1977","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.tcm.2020.08.002_bib0069","first-page":"1276","article-title":"Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis","volume":"44","author":"Kaufman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0070","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.1987.00370100119019","article-title":"Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature","volume":"147","author":"Manolis","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0071","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0002-9149(89)90077-5","article-title":"Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone","volume":"63","author":"Manolis","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0072","first-page":"21","article-title":"Dronedarone: the hope and the hype","volume":"6","author":"Manolis","year":"2011","journal-title":"Rhythmos"},{"key":"10.1016\/j.tcm.2020.08.002_bib0073","first-page":"1","article-title":"Did PALLAS deliver the final blow to dronedarone?","volume":"7","author":"Manolis","year":"2012","journal-title":"Rhythmos"},{"key":"10.1016\/j.tcm.2020.08.002_bib0074","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jacc.2004.04.056","article-title":"Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter","volume":"44","author":"Chiladakis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0075","first-page":"7","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators","volume":"348","author":"Waldo","year":"1996","journal-title":"Survival With Oral d-Sotalol. Lancet"},{"key":"10.1016\/j.tcm.2020.08.002_bib0076","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.hjc.2018.02.003","article-title":"Use of intravenous vernakalant for atrial fibrillation conversion in the regular ward under only bedside monitoring","volume":"60","author":"Manolis","year":"2019","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0077","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/jac\/dky139","article-title":"How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?","volume":"73","author":"Cattaneo","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tcm.2020.08.002_bib0078","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clpt.2004.02.008","article-title":"Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers","volume":"76","author":"Ding","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tcm.2020.08.002_bib0079","article-title":"The role of the autonomic nervous system in cardiac arrhythmias: the neuro-cardiac axis, more foe than friend?","author":"Manolis","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.tcm.2020.08.002_bib0080","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/acschemneuro.0c00265","article-title":"Autonomic brain centers and pathophysiology of COVID-19","volume":"11","author":"Chigr","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.tcm.2020.08.002_bib0081","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1797","article-title":"The vagus nerve and the nicotinic anti-inflammatory pathway","volume":"4","author":"Ulloa","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.tcm.2020.08.002_bib0082","first-page":"1","article-title":"Implications for neuromodulation therapy to control inflammation and related organ dysfunction in COVID-19","author":"Fudim","year":"2020","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.tcm.2020.08.002_bib0083","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2020.08.002_bib0084","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neubiorev.2020.02.011","article-title":"Anatomical and clinical implications of vagal modulation of the spleen","volume":"112","author":"Bassi","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.tcm.2020.08.002_bib0085","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1097\/CCM.0000000000001606","article-title":"Molecular mechanisms linking autonomic dysfunction and impaired cardiac contractility in critical illness","volume":"44","author":"Ackland","year":"2016","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.tcm.2020.08.002_bib0086","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jinf.2020.07.012","article-title":"Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia","volume":"81","author":"Liu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.tcm.2020.08.002_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for the diagnosis and risk-stratification of myocardial injury in COVID-19: JACC review topic of the week","author":"Sandoval","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0088","doi-asserted-by":"crossref","DOI":"10.5694\/mja2.50714","article-title":"Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement","author":"Zaman","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.tcm.2020.08.002_bib0089","first-page":"42","article-title":"Pediatric inflammatory multisystem syndrome temporally associated with SARS-Cov-2 infection (PIMS-TS): Kawasaki-like multisystem inflammatory syndrome in children (MIS-C) during the COVID-19 pandemic with predominant myocarditis","volume":"15","author":"Manolis","year":"2020","journal-title":"Rhythmos"},{"key":"10.1016\/j.tcm.2020.08.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/ppul.24991","article-title":"Clinical characteristics of COVID-19 in children: a systematic review","author":"Yasuhara","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.tcm.2020.08.002_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.06.033","article-title":"Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval","author":"Samuel","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0092","first-page":"euaa187","article-title":"HRS\/EHRA\/APHRS\/LAHRS\/ACC\/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic","author":"Varma","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2020.08.002_bib0093","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.hrthm.2017.03.038","article-title":"2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring\/telemetry","volume":"14","author":"Steinberg","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2020.08.002_bib0094","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehaa404","article-title":"TeleCheck-AF for COVID-19","volume":"41","author":"Linz","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820301079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173820301079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:59:53Z","timestamp":1760936393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173820301079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1050173820301079"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2020.08.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 infection and cardiac arrhythmias","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}